Anticoagulation in a Neurosurgical Patient with Heparin-Induced Thrombocytopenia Type II with Argatroban and Fondaparinux after Clipping of an Intracranial Aneurysm

被引:3
|
作者
Kerz, Thomas [1 ]
Schinzel, Helmut [2 ]
机构
[1] Johannes Gutenberg Univ Mainz, Sch Med, Dept Neurosurg, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Sch Med, Med Clin & Policlin 2, Mainz, Germany
关键词
Heparin-induced thrombocytopenia; HIT II; Neurosurgery; Argatroban; Fondaparinux;
D O I
10.1159/000205964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Therapeutic anticoagulation in patients after a major neurosurgical procedure remains critical because of the risk of a major intracranial bleed. Novel drugs could play a beneficial role in this setting. Case Report: We describe a patient with heparin-induced thrombocytopenia type II and pulmonary embolism who was anticoagulated with argatroban and, later, with fondaparinux. No intracranial bleeding was detected when anticoagulation was performed with argatroban and, later, fondaparinux. Conclusion: Both substances could have therapeutic potential in this context.
引用
收藏
页码:141 / 143
页数:3
相关论文
共 50 条
  • [41] Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
    Yoshihiko Ogawa
    Toshihiko Nagata
    Taisuke Akiyama
    Koji Nishida
    Junji Kumasawa
    Michihiko Kohno
    Hisakazu Kohata
    Iwao Gohma
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 1012 - 1014
  • [42] Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia A case report
    He, Yumiao
    He, Huaiwu
    Liu, Dawei
    Long, Yun
    Su, Longxiang
    Cheng, Wei
    MEDICINE, 2018, 97 (37)
  • [43] Argatroban anticoagulation during renal replacement therapy in patients with heparin-induced thrombocytopenia.
    Reddy, BV
    Grossman, EJ
    Nahlik, L
    Trevino, S
    Murray, PT
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 604A - 604A
  • [44] Reducing Harm Associated with Anticoagulation Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia
    Hursting, Marcie J.
    Soffer, Joseph
    DRUG SAFETY, 2009, 32 (03) : 203 - 218
  • [45] Argatroban anticoagulation in obese versus nonobese patients: Implications for treating heparin-induced thrombocytopenia
    Rice, Lawrence
    Hursting, Marcie J.
    Baillie, G. Mark
    McCollum, David A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (08): : 1028 - 1034
  • [46] Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support
    Potter, Katherine E.
    Raj, Ashok
    Sullivan, Janice E.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (04) : 265 - 268
  • [47] Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia - a case report
    Osawa, Eduardo Atsushi
    Guerra Soares Brandao, Antonio Adolfo
    Americo, Andre Dias
    Maciel, Alexandre Toledo
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2022, 44 (01) : 108 - 111
  • [48] Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia
    Wasowicz, M
    Vegas, A
    Borger, MA
    Harwood, S
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2005, 52 (10): : 1093 - 1098
  • [49] Heparin-induced thrombocytopenia type-II
    Wagner, AD
    Kleber, G
    Lindner, A
    Potzsch, B
    Fleig, WE
    INTERNIST, 1998, 39 (07): : 766 - 769
  • [50] Determination of heparin-induced IgG antibody in heparin-induced thrombocytopenia type II
    Wang, LC
    Huhle, G
    Malsch, R
    Hoffmann, V
    Song, XLH
    Harenberg, J
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999, 29 (03) : 232 - 237